Junsu Kim

MS/PhD candidate (2023. 03-Present)

4. Kim, H. J., Jun, H., Lee, H. B., Eom, S., Kim, J., Jeon, J. P., Park, S. H., and Kang, S.,* Leukemia-Targeting NK cell Nanoengagers Effectively Promote Robust NK Activation and Potent Anti-Acute Myeloid Leukemia Response. J. Nanobiotechnology, 2026, Accepted.

3. Jeong, D.,# Kim, J.,# Kim, Y., Jun, H., Eom, S., and Kang, S.,* HER2-targeting and TRAIL-presenting Protein Nanoparticles Induce a Concentration-Dependent Biphasic Response in HER2-Positive Breast Cancer Cells. Biomacromolecules, 2026, Accepted.  

      #: Equal contribution

2. Eom, S.,# Kim, J.,# Noh, Y., Yun, E., Kim, H. E., Roh, H., Park, T. J., Cha, C., and Kang, S.,* Self-crosslinkable protein hydrogel stamps for rapid and wash-free immunostaining in cells and tissues. Acta Biomater. 2026,  212, 300-309.

      #: Equal contribution

      한국을 빛낸 사람들 (BRIC) 소개

1. Jun, H.,# Kim, J.,# Eom, S., Jeong, D., and Kang, S.,* Targeted Therapy for CD13-overexpressing Triple-Negative Breast Cancers Using Apoptosis-inducing Protein Cage Nanoparticles. Macromol. Biosci. 2026,  26, e00645.

      #: Equal contribution